Analyzing mechanism of oncogenesis by human papillomavirus
人乳头瘤病毒致瘤机制分析
基本信息
- 批准号:14026065
- 负责人:
- 金额:$ 18.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research on Priority Areas
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Transforming activity of E6 requires the PDZ-binding motif at the carboxy terminus conserved among high risk HPV E6 proteins. Since we first reported the hDLG as the E6 target, hScrib, MUPP1, and MUGI have been reported as the similar targets. We identified PSD95 as a novel target. The fact that HPV positive cervical cancer cell lines showed very low expression levels of PSD95, allowed us speculate that PSD95 might function as tumor suppressor. Overexpression of PSD95 in CaSki cells unchanged the growth in a culture dish but significantly reduced the growth both in soft agar medium and nude mice. It was also suggested that PSD95 was ubiquitinated by E6/E6AP complex and degraded by proteosome.It has long been unknown how E6 activates telomerase in normal human keratinocyte and mammary epithelial cells. We found that E6/E6AP complex bound to a transcriptional repressor, NFX-1. From NIX-1 gene, 123 kDa (NFX1-123) and 91kDa (NFX1-91) proteins were expressed. We found E6/E6AP complex specifically enhanced degradation of NFX1-91 which functioned as transcriptional repressor of hTERT promoter, indicating that the enhanced degradation of NFX-1 is at least a mechanism to activate telomerase by E6.We suggest that the upregulation of hWAPL, which is preferentially overexpressed in cervical cancers, might be a mechanism which induces chromosomal instability in normal cells by E6 and E7. Human WAPL (hWAPL) is a human homologue of Drosophila wing apart-like gene. The gene product binds to heterochromatin and its overexpression can induce chromosomal instability in cultured cells.
E6的转化活性需要在高危HPV E6蛋白之间保守的羧基末端的PDZ结合基序。自从我们首次报道hDLG作为E6靶标以来,hScrib、MUPP1和Mugi被报道为类似的靶标。我们将PSD95确定为一个新的靶点。HPV阳性的宫颈癌细胞株PSD95的表达水平很低,这一事实使我们推测PSD95可能具有肿瘤抑制作用。在CaSki细胞中过表达PSD95不影响培养皿中的生长,但显着降低软琼脂和裸鼠的生长。也有人认为PSD95被E6/E6AP复合体泛素化,并被蛋白酶体降解。长期以来,E6如何激活正常人角质形成细胞和乳腺上皮细胞的端粒酶一直是未知的。我们发现E6/E6AP复合体与转录抑制因子NFX-1结合。Nix-1基因表达了123 kDa(NFX1-123)和91 kDa(NFX1-91)蛋白。我们发现E6/E6AP复合体特异性地促进了作为hTERT启动子转录抑制因子的NFX1-91的降解,表明NFX-1的增强降解至少是E6激活端粒酶的机制之一。我们认为,在宫颈癌中优先过表达的hWAPL的上调可能是E6和E7导致正常细胞染色体不稳定的机制之一。人WAPL(HWAPL)是果蝇类翼状基因的人类同源基因。该基因产物与异染色质结合,其过度表达可导致培养细胞的染色体不稳定。
项目成果
期刊论文数量(58)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Successful immortalization of endometrial glandular cells with normal structural and functional characteristics
- DOI:10.1016/s0002-9440(10)63583-3
- 发表时间:2003-12-01
- 期刊:
- 影响因子:6
- 作者:Kyo, S;Nakamura, M;Inoue, M
- 通讯作者:Inoue, M
Immortalization of human fetal cells:: The life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway
- DOI:10.1091/mbc.e04-07-0652
- 发表时间:2005-03-01
- 期刊:
- 影响因子:3.3
- 作者:Terai, M;Uyama, T;Kiyono, T
- 通讯作者:Kiyono, T
Bruemmer D: "Expression of minichromosome maintenance proteins in vascular smooth muscle cells is ERK/MAPK dependent."Exp Cell Res.. 290. 28-37 (2003)
Bruemmer D:“血管平滑肌细胞中微染色体维持蛋白的表达依赖于 ERK/MAPK。”Exp Cell Res.. 290. 28-37 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishiyama, Y., and Tsurumi T. Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.
Nishiyama, Y. 和 Tsurumi T. 抑制 S 期细胞周期蛋白依赖性激酶活性可阻断 Epstein-Barr 病毒立即早期和早期基因的表达,从而防止病毒裂解复制。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Kudoh;A.;Daikoku;T.;Sugaya;Y;Isomura;H.;Fujita;M.;Kiyono;T.
- 通讯作者:T.
Can the life span of human marrow stromal cells be prolonged by Bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic Differentiation?
Bmi-1、E6、E7 和/或端粒酶能否在不影响心肌分化的情况下延长人骨髓基质细胞的寿命?
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Uzaslan E.;et al.;Danno D;Takeda Y
- 通讯作者:Takeda Y
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIYONO Tohru其他文献
KIYONO Tohru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIYONO Tohru', 18)}}的其他基金
Development of eradicative cancer treatment based on synthetic lethality of induced cancer stem cells
基于诱导癌症干细胞的综合致死性开发根除性癌症治疗
- 批准号:
16H04701 - 财政年份:2016
- 资助金额:
$ 18.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of telomerase activation by human papillomavirus E6
人乳头瘤病毒E6激活端粒酶的分子机制
- 批准号:
11138267 - 财政年份:1999
- 资助金额:
$ 18.24万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
相似海外基金
CHEMOTHERAPY IN SQUAMOUS CANCER OF UTERINE CERVIX AND VULVA
子宫颈和外阴鳞状癌的化疗
- 批准号:
3971237 - 财政年份:
- 资助金额:
$ 18.24万 - 项目类别:
CHEMOTHERAPY IN SQUAMOUS CANCER OF UTERINE CERVIX AND VULVA
子宫颈和外阴鳞状癌的化疗
- 批准号:
4698920 - 财政年份:
- 资助金额:
$ 18.24万 - 项目类别: